Interestingly, these peptide variants are also frequently detected in MS patients (15), suggesting that the HLA-E pathway may facilitate more frequent EBV reactivation, which, in turn, could increase the risk of EBV-associated autoimmune and lymphoproliferative diseases. The gene discussed is HLA-E; the disease is myeloid sarcoma.